Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Melissa Johnson

Sarah Cannon Research Institute, Nashville, TN

Melissa Johnson, MD is the Program Director of Lung Cancer Research at the Sarah Cannon Cancer Institute. Since joining Sarah Cannon in 2014, Dr. Johnson has served as the Associate Director of Lung Cancer Research at Sarah Cannon Research Institute, supporting the growth of early phase compounds in thoracic malignancies. Sarah Cannon Research Institute is one of the world’s leading clinical research organizations conducting community-based clinical trials throughout the United States and United Kingdom.

Dr Johnson received her undergraduate degree from the University of North Carolina, Chapel Hill where she was a Morehead Scholar, and her medical degree from the University of Pennsylvania. She completed her residency in internal medicine at New York Presbyterian/Weill Cornell Medical Center and her fellowship in medical oncology and hematology at Memorial Sloan Kettering Cancer Center where she also served as chief fellow for one year. She spent four years as a faculty member at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Feinberg School of Medicine, where she was a founding member of the Northwestern Medical Developmental Therapeutics Institute.